Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SPOK

Spok Holdings Inc

10.31

Aug 21 • 3:59 PM ET -0.13 (-1.25%)

10.38

Aftermarket • 7:39 PM ET +0.07 (0.70%)

Healthcare Health Information Services USA Micro NASD

Peers: CARL LFMD SY SLP EVH HCAT PHR DH CERT TDOC

| Held by: VTI IWM VXF IWN VTWO DES FDM DFAT VOX IWC

Index	RUT
Market Cap	215.67M
Enterprise Value	204.83M
Income	12.24M
Sales	135.97M
Book/sh	6.69
Cash/sh	0.79
Dividend Est.	-
Dividend TTM	1.25 (12.10%)
Dividend Ex-Date	Aug 19, 2026
Dividend Gr. 3/5Y	0.00% 20.11%
Payout	165.72%
Employees	421
IPO	May 30, 2002

P/E	17.75
Forward P/E	-
PEG	-
P/S	1.59
P/B	1.54
P/C	13.00
P/FCF	8.49
EV/EBITDA	9.29
EV/Sales	1.51
Quick Ratio	1.09
Current Ratio	1.09
Debt/Eq	0.04
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	0.58
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-11.64% -
Sales past 3/5Y	1.27% -1.17%
EPS Y/Y TTM	-29.34%
Sales Y/Y TTM	-3.39%
EPS Q/Q	-10.94%
Sales Q/Q	-1.89%
Earnings	Jul 29 AMC
EPS/Sales Surpr.	- -

Insider Own	2.20%
Insider Trans	1.52%
Inst Own	57.56%
Inst Trans	2.26%
ROA	6.06%
ROE	8.42%
ROIC	8.54%
Gross Margin	62.53%
Oper. Margin	13.55%
Profit Margin	9.00%
SMA20	-6.09%
SMA50	-3.76%
SMA200	-13.29%
Trades

Shs Outstand	20.91M
Shs Float	20.46M
Short Float	2.82%
Short Ratio	3.35
Short Interest	0.58M
52W High	18.26 -43.54%
52W Low	9.95 3.62%
Volatility	2.02% 2.60%
ATR (14)	0.28
RSI (14)	35.01
Beta	0.42
Rel Volume	1.77
Avg Volume	172.35K
Volume	304,586

Perf Week	-5.93%
Perf Month	-1.90%
Perf Quarter	-6.44%
Perf Half Y	-23.97%
Perf YTD	-21.83%
Perf Year	-41.69%
Perf 3Y	-19.95%
Perf 5Y	28.71%
Perf 10Y	-37.64%
Recom	3.00
Target Price	14.00
Prev Close	10.44
Price	10.31
Change %	-1.25%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-26	Downgrade	B. Riley Securities	Buy → Neutral	$14
Feb-27-25	Upgrade	B. Riley Securities	Neutral → Buy	$15 → $20
Sep-26-24	Initiated	B. Riley Securities	Neutral	$15
Dec-19-22	Resumed	Lake Street	Buy	$15
Sep-23-22	Initiated	Lake Street	Buy	$14

Aug-06-26 08:30AM	Spok-Powered Hospitals Recognized on 2026-2027 U.S. News & World Report's Best Hospitals Honor Roll (Business Wire)
Jul-30-26 08:30AM	Spok Holdings, Inc. Q2 2026 Earnings Call Summary (Moby)
01:02AM	Spok Holdings Inc (SPOK) (Q2 2026) Earnings Call Highlights: Record Adjusted EBITDA and Strong ... (GuruFocus.com)
Jul-29-26 05:45PM	Spok: Q2 Earnings Snapshot (Associated Press)
04:05PM	Spok Reports Second Quarter 2026 Results (Business Wire)
11:00AM	Loading…
Jul-22-26 11:00AM	Spok Sets Date to Report Second Quarter 2026 Results (Business Wire)
Jun-24-26 04:05PM	Spok Announces Sale of Spectrum Licenses to Sensus (Business Wire)
Apr-29-26 04:51PM	Spok: Q1 Earnings Snapshot (Associated Press)
04:05PM	Spok Reports First Quarter 2026 Results (Business Wire)
Apr-22-26 04:05PM	Spok Sets Date to Report First Quarter 2026 Results (Business Wire)
Apr-14-26 04:05PM	Spok Announces Strategic Realignment and Prioritization Plan to Maintain Long-Term Profitability and Sustainable Growth (Business Wire)
Mar-06-26 01:01PM	Is the Options Market Predicting a Spike in Spok Holdings Stock? (Zacks)
Feb-26-26 03:08AM	Spok Q4 Earnings Call Highlights (MarketBeat) -13.44%
12:02AM	Spok Holdings Inc (SPOK) Q4 2025 Earnings Call Highlights: Strong Software Growth Amid Wireless ... (GuruFocus.com)
Feb-25-26 05:13PM	Spok: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Spok Reports Fourth Quarter And Full Year 2025 Results (Business Wire)
Feb-18-26 11:43AM	Spok Sets Date to Report Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-04-26 08:30AM	Spok Earns Top Client Satisfaction Scores for Ninth Consecutive Year (Business Wire)
Jan-28-26 07:45AM	AT&T (T) Q4 Earnings and Revenues Beat Estimates (Zacks)
Dec-23-25 08:56AM	Is the Options Market Predicting a Spike in Spok Stock? (Zacks)
Dec-15-25 09:02AM	3 Ultra-High Dividend Yield Picks for the New Year (MarketBeat)
Nov-12-25 08:30AM	15th Annual Spok Survey Highlights Shifting Clinical Communication Opportunities and Obstacles (Business Wire)
Nov-04-25 08:10PM	Spok Holdings Inc (SPOK) Q3 2025 Earnings Call Highlights: Navigating Revenue Challenges with ... (GuruFocus.com)
Oct-29-25 05:50PM	Spok Holdings (SPOK) Q3 Earnings and Revenues Miss Estimates (Zacks) -12.52%
04:43PM	Spok: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Spok Reports Third Quarter 2025 Results (Business Wire)
Oct-28-25 09:59AM	Spok Holdings Inc (SPOK) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-22-25 10:30AM	Spok Sets Date to Report Third Quarter 2025 Results (Business Wire)
07:45AM	AT&T (T) Q3 Earnings and Revenues Lag Estimates (Zacks)
Oct-09-25 08:30AM	U.S. News & World Report Names Spok-Powered Hospitals to Best Children's Hospitals Honor Roll (Business Wire)
12:00PM	Loading…
Aug-05-25 12:00PM	Here's Why Spok Holdings (SPOK) is a Great Momentum Stock to Buy (Zacks)
08:30AM	Spok-Powered Hospitals Achieve Recognition on U.S. News & World Reports Best Hospitals Honor Roll (Business Wire)
05:50AM	3 Healthcare Stocks Paying the Highest Dividends of 2025 (Motley Fool)
Aug-04-25 12:45PM	3 Reasons Growth Investors Will Love Spok (SPOK) (Zacks)
Aug-01-25 12:00PM	All You Need to Know About Spok (SPOK) Rating Upgrade to Buy (Zacks)
08:50AM	What Makes Spok (SPOK) a Good Fit for 'Trend Investing' (Zacks)
Jul-31-25 03:34AM	Spok Holdings Inc (SPOK) Q2 2025 Earnings Call Highlights: Strong Software Growth and Increased ... (GuruFocus.com) +7.69%
Jul-30-25 05:40PM	Spok Holdings (SPOK) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:38PM	Spok: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Spok Reports Second Quarter 2025 Results (Business Wire)
Jul-29-25 09:59AM	Spok Holdings Inc (SPOK) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-23-25 03:07PM	Spok Sets Date to Report Second Quarter 2025 Results (Business Wire)
May-01-25 03:19AM	Spok Holdings Inc (SPOK) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +13.18%
Apr-30-25 08:55PM	Spok Holdings, Inc. (SPOK) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:10PM	Spok Holdings (SPOK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:10PM	Spok: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Spok Reports First Quarter 2025 Results (Business Wire)
Apr-23-25 02:29PM	Spok Sets Date to Report First Quarter 2025 Results (Business Wire)
07:45AM	AT&T (T) Q1 Earnings Miss Estimates (Zacks)
Apr-10-25 11:07AM	Gogo (GOGO) Moves 15.7% Higher: Will This Strength Last? (Zacks)
Mar-25-25 08:30AM	Spok Achieves Top Client Satisfaction Scores for Eighth Consecutive Year (Business Wire)
Mar-24-25 06:03PM	Spok Holdings (SPOK): Among Top Dividend Stocks that Pay More than the US Average Rental Yield (InsiderMonkey)
Feb-27-25 07:25AM	Q4 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
02:25AM	Spok Holdings Inc (SPOK) Q4 2024 Earnings Call Highlights: Strong Software Growth Amid Revenue ... (GuruFocus.com)
Feb-26-25 06:15PM	Spok Holdings (SPOK) Q4 Earnings and Revenues Miss Estimates (Zacks)
05:17PM	Spok: Q4 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-25-25 10:57AM	Earnings To Watch: Spok Holdings Inc (SPOK) Reports Q4 2024 Result (GuruFocus.com)
Feb-19-25 04:00PM	Spok Sets Date to Report Fourth Quarter and Full Year 2024 Results (Business Wire)
Nov-01-24 07:01AM	Spok Holdings Inc (SPOK) Q3 2024 Earnings Call Highlights: Strong Software Bookings Amid ... (GuruFocus.com)
Oct-30-24 05:35PM	Spok: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Third Quarter 2024 Results (Business Wire)
Oct-29-24 09:16AM	Earnings To Watch: Spok Holdings Inc (SPOK) Reports Q3 2024 Result (GuruFocus.com)
Oct-24-24 09:15AM	Spok Customers Highlighted on U.S. News & World Reports Childrens Best Hospitals Honor Roll (Business Wire)
Oct-23-24 02:00PM	Spok Sets Date to Report Third Quarter 2024 Results (Business Wire)
Oct-22-24 09:15AM	14th Annual Spok Survey Offers Insights Into Evolving Healthcare Communications Challenges and Opportunities (Business Wire)
Aug-21-24 07:01PM	Insider Sale: COO Michael Wallace Sells 25,000 Shares of Spok Holdings Inc (SPOK) (GuruFocus.com)
Jul-25-24 12:00PM	Spok Holdings (SPOK) Q2 Earnings and Revenues Decline Y/Y (Zacks) -6.50%
09:28AM	Q2 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-24-24 04:48PM	Spok: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Second Quarter 2024 Results (Business Wire)
Jul-18-24 10:54AM	Spok Customers Recognized on U.S. News & World Report's Best Hospitals Honor Roll (Business Wire)
Jul-17-24 10:29AM	Spok Sets Date to Report Second Quarter 2024 Results (Business Wire)
Jul-08-24 09:15AM	Spok Celebrates a Decade of Excellence and Innovation (Business Wire)
May-02-24 12:36PM	Spok Holdings, Inc. (NASDAQ:SPOK) Q1 2024 Earnings Call Transcript (Insider Monkey) -8.08%
08:10AM	Q1 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:40AM	Spok Holdings Inc (SPOK) Q1 2024 Earnings Call Transcript Highlights: A Strong Start with ... (GuruFocus.com)
May-01-24 10:55PM	SPOK Stock Earnings: Spok Holdings Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Spok Holdings Inc (SPOK) Reports Strong Q1 2024 Earnings, Surpassing Revenue Expectations (GuruFocus.com)
05:50PM	Spok: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports First Quarter 2024 Results (Business Wire)
Apr-24-24 09:00AM	Spok Sets Date to Report First Quarter 2024 Results (Business Wire)
Apr-02-24 09:15AM	Spok Achieves Top Client Satisfaction Scores for Seventh Consecutive Year (Business Wire)
Mar-30-24 05:00PM	Sub-$20 Superstars: 3 Stocks Ready to Double Your Money (InvestorPlace)
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-07-24 09:15AM	Spok to Showcase the Latest Advancements to Top-Rated Secure Healthcare Communication and Collaboration Platform at HIMSS24 (Business Wire)
Mar-06-24 10:00AM	Spok to Present at Sidoti Virtual Investor Conference (Business Wire)
Mar-04-24 11:29PM	Insider Sell: COO Michael Wallace Sells 40,000 Shares of Spok Holdings Inc (SPOK) (GuruFocus.com)
Feb-28-24 05:14PM	3 Underestimated Stocks With 900% Upside Potential (InvestorPlace)
02:27PM	The Dividend Promise: 3 Stocks Set to Deliver in March 2024 (InvestorPlace)
Feb-22-24 11:22AM	Spok Holdings, Inc. (NASDAQ:SPOK) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.25%
06:54AM	Q4 2023 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 05:25PM	Spok: Q4 Earnings Snapshot (Associated Press Finance)
04:45PM	Spok Holdings Inc (SPOK) Reports Revenue Growth and Record Software Bookings in 2023 (GuruFocus.com)
04:10PM	Spok Reports Fourth Quarter And Full Year 2023 Results (Business Wire)
Feb-17-24 02:00PM	Hidden Gems: 3 Stocks Under $20 With 5X Growth Potential by 2027 (InvestorPlace)
Feb-14-24 04:10PM	Spok Sets Date to Report Fourth Quarter and Full Year 2023 Results (Business Wire)
Jan-23-24 06:07PM	3 Small-Cap Stocks Ready to Rocket by 2025 (InvestorPlace)
Dec-25-23 02:53PM	From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune (InvestorPlace)
Dec-01-23 08:59AM	Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio (InvestorPlace)

Spok Holdings, Inc. engages in the provision of communication solutions. It provides call center operations, clinical alerting and notifications, one-way and advanced two-way wireless messaging services, mobile communications and public safety solutions. The company was founded in 1965 and is headquartered in Plano, TX.

PresidentMr. Vincent D. Kelly CPA

CFO & COOMr. Michael W. Wallace CPA

Corporate Secretary & TreasurerMs. Sharon Woods Keisling

Chief Information Officer & Chief Information Security OfficerMr. Michael Czop

Chief Compliance Officer and VP of HR & AdministrationMs. Renee Hall

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COURNOYER CHRISTINE	Director	Aug 10 '26	Sale	11.28	8,320	93,870	16,261	Aug 11 04:30 PM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Aug 10 '26	Sale	11.30	20,000	225,940	6,036	Aug 11 04:30 PM
Christine M. Cournoyer	Director	Aug 10 '26	Proposed Sale	11.33	8,320	94,266		Aug 10 05:14 PM
Woods-Keisling Sharon	Officer	Aug 10 '26	Proposed Sale	11.28	20,000	225,600		Aug 10 02:51 PM
Stein Todd J	Director	Jun 16 '26	Buy	10.41	35,211	366,705	532,771	Jun 17 04:30 PM
KELLY VINCENT D	President & CEO	May 12 '26	Buy	10.70	5,000	53,477	167,565	May 12 04:30 PM
KELLY VINCENT D	President & CEO	May 11 '26	Buy	10.67	5,000	53,342	162,565	May 12 04:30 PM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	May 05 '26	Sale	11.00	10,000	110,036	26,036	May 06 04:30 PM
Woods-Keisling Sharon	Officer	May 05 '26	Proposed Sale	10.87	10,000	108,700		May 05 10:33 AM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Mar 04 '26	Option Exercise	12.14	11,447	138,967	37,071	Mar 04 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Mar 04 '26	Option Exercise	12.14	30,525	370,574	82,774	Mar 04 04:30 PM
KELLY VINCENT D	President & CEO	Mar 04 '26	Option Exercise	12.14	48,840	592,918	171,548	Mar 04 04:30 PM
Rice Calvin	Chief Financial Officer & CAO	Mar 04 '26	Option Exercise	12.14	13,736	166,755	25,998	Mar 04 04:30 PM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Jan 05 '26	Option Exercise	13.19	8,707	114,845	28,707	Jan 07 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Jan 05 '26	Option Exercise	13.19	22,865	301,589	63,234	Jan 07 04:30 PM
KELLY VINCENT D	President & CEO	Jan 05 '26	Option Exercise	13.19	37,430	493,702	140,247	Jan 07 04:30 PM
Rice Calvin	Chief Financial Officer & CAO	Jan 05 '26	Option Exercise	13.19	11,452	151,052	18,487	Jan 07 04:30 PM
Stein Todd J	Director	Sep 04 '25	Sale	18.08	38,008	687,359	497,560	Sep 05 04:30 PM
Stein Todd J	Director	Sep 03 '25	Sale	18.02	43,335	780,921	515,042	Sep 04 04:30 PM
Stein Todd J	Director	Sep 02 '25	Sale	18.05	22,711	409,988	532,932	Sep 04 04:30 PM
Stein Todd J	Director	Aug 25 '25	Sale	17.95	11,766	211,209	543,379	Aug 26 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Aug 25 '25	Sale	17.87	10,806	193,118	40,369	Aug 26 04:30 PM
WALLACE MICHAEL W	Officer	Aug 25 '25	Proposed Sale	17.98	11,000	197,780		Aug 25 02:32 PM

Open in Screener

CDNA

Caredx Inc

48.61

Aug 21 • 3:59 PM ET +1.62 (3.45%)

48.86

Aftermarket • 7:56 PM ET +0.25 (0.51%)

Healthcare Diagnostics & Research USA Mid NASD

Peers: VCYT WGS GRAL BLLN NTRA DGX LH A DHR TMO

| Held by: ARKG VTI IWM XBI VXF IWO PBE IBB VTWO SCHA

Index	RUT
Market Cap	2.51B
Enterprise Value	2.16B
Income	111.01M
Sales	458.09M
Book/sh	8.27
Cash/sh	7.22
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	765
IPO	Jul 17, 2014

P/E	23.43
Forward P/E	35.87
PEG	0.73
P/S	5.49
P/B	5.88
P/C	6.73
P/FCF	29.69
EV/EBITDA	120.22
EV/Sales	4.72
Quick Ratio	4.51
Current Ratio	4.58
Debt/Eq	0.05
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	2.07
EPS next Y	1.35
EPS next Q	0.25
EPS this Y	109.20%
EPS next Y	11.68%
EPS next 5Y	49.46%
EPS past 3/5Y	34.67% 0.09%
Sales past 3/5Y	5.68% 14.59%
EPS Y/Y TTM	90.73%
Sales Y/Y TTM	34.41%
EPS Q/Q	1412.42%
Sales Q/Q	52.23%
Earnings	Jul 30 AMC
EPS/Sales Surpr.	59.41% 15.69%

Insider Own	9.05%
Insider Trans	-6.96%
Inst Own	100.12%
Inst Trans	1.17%
ROA	22.72%
ROE	29.49%
ROIC	25.30%
Gross Margin	70.11%
Oper. Margin	-0.40%
Profit Margin	24.23%
SMA20	9.21%
SMA50	36.27%
SMA200	108.15%
Trades

Shs Outstand	51.48M
Shs Float	47.05M
Short Float	13.04%
Short Ratio	5.88
Short Interest	6.14M
52W High	49.76 -2.31%
52W Low	11.88 309.18%
Volatility	4.82% 5.09%
ATR (14)	2.18
RSI (14)	71.74
Beta	2.42
Rel Volume	1.11
Avg Volume	1.04M
Volume	1,160,457

Perf Week	7.26%
Perf Month	29.25%
Perf Quarter	125.36%
Perf Half Y	158.56%
Perf YTD	158.01%
Perf Year	288.57%
Perf 3Y	463.92%
Perf 5Y	-33.86%
Perf 10Y	912.73%
Recom	1.86
Target Price	52.33
Prev Close	46.99
Price	48.61
Change %	3.45%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-03-26	Upgrade	Craig Hallum	Hold → Buy	$64
Jan-06-26	Downgrade	Craig Hallum	Buy → Hold	$26
Aug-26-25	Initiated	William Blair	Mkt Perform
Jan-15-25	Upgrade	Wells Fargo	Underweight → Equal Weight	$28 → $24
Aug-28-24	Initiated	Wells Fargo	Underweight	$28
Aug-19-24	Upgrade	BTIG Research	Neutral → Buy	$40
May-13-24	Downgrade	Raymond James	Outperform → Mkt Perform
May-01-24	Upgrade	Craig Hallum	Hold → Buy	$15
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight	$10
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform	$12
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight	$19 → $9
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold	$26 → $9
Apr-25-22	Initiated	Stephens	Overweight	$50
Jul-20-21	Resumed	BTIG Research	Buy	$115
Jun-03-21	Initiated	Goldman	Buy	$95
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy	$47 → $55
Oct-08-20	Reiterated	H.C. Wainwright	Buy	$45 → $47

Show Previous Ratings

Aug-07-26 04:01PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-03-26 01:57PM	SNOW, CDNA Stocks Hit Fresh 52-Week Highs Whats Driving Investor Optimism Today? (Stocktwits) +9.47%
Jul-31-26 06:45PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +14.72%
03:11PM	Medical Test Name Explodes To A High After Earnings (Investor's Business Daily)
Jul-30-26 04:22PM	CareDx: Q2 Earnings Snapshot (Associated Press) +7.60%
04:01PM	Loading…
04:01PM	CareDx Announces Second Quarter 2026 Financial Results (Business Wire)
Jul-16-26 09:43AM	CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA) (InvestorsHub) +35.60%
08:35AM	CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 (Business Wire)
08:30AM	CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination (Business Wire)
Jul-02-26 06:41PM	CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology (Exec Edge)
Jul-01-26 04:05PM	CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology (Business Wire)
Jun-30-26 04:05PM	CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific (Business Wire)
Jun-18-26 07:05AM	CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress (Business Wire) +11.50%
Jun-16-26 04:05PM	CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology (Business Wire)
May-20-26 04:01PM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
04:05PM	Loading…
May-11-26 04:05PM	CareDx Announces Dismissal of 2021 Qui Tam Suit (Business Wire)
May-01-26 04:01PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-29-26 08:30AM	CareDx, Inc Q1 2026 Earnings Call Summary (Moby) -5.07%
03:10AM	CareDx Inc (CDNA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com)
Apr-28-26 08:41PM	CareDx to Acquire Naveris to Expand Into Cancer MRD Testing (Exec Edge)
04:18PM	CareDx: Q1 Earnings Snapshot (Associated Press)
04:05PM	CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing (Business Wire)
04:01PM	CareDx Announces First Quarter 2026 Financial Results (Business Wire)
Apr-21-26 04:01PM	CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual Meeting (Business Wire)
Apr-20-26 07:05AM	CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing (Business Wire)
Apr-16-26 09:49AM	Why Diagnostics Names CareDx And QuidelOrtho Just Diverged (Investor's Business Daily) +27.60%
Apr-15-26 04:30PM	CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results (Business Wire)
Apr-14-26 04:01PM	CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 (Business Wire)
Mar-07-26 05:02PM	CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference (MarketBeat)
Mar-05-26 04:01PM	CareDx Announces VANTx, an AIPowered Clinical Data & Analytics Platform Built on CareDxs Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets (Business Wire)
04:01PM	Loading…
Feb-27-26 04:01PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-25-26 08:02PM	CareDx, Inc Q4 2025 Earnings Call Summary (Moby)
12:04AM	CareDx Inc (CDNA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com)
Feb-24-26 11:11PM	CareDx Q4 Earnings Call Highlights (MarketBeat)
08:00PM	CareDx (CDNA) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:30PM	CareDx (CDNA) Q4 Earnings Miss Estimates (Zacks)
05:15PM	CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer (Business Wire)
04:21PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	CareDx Announces Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-18-26 08:00AM	CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference (Business Wire)
Feb-16-26 11:32AM	CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT (Zacks)
Feb-13-26 01:09AM	CareDx Expands Transplant Plus Into Cell Therapy, Showcases AlloHeme AML/MDS Relapse Data (MarketBeat)
Feb-12-26 07:05AM	CareDx Announces Clinical Validation Results for AlloHeme, the First AI-Powered NGS Surveillance Solution for AML and MDS Post-Cell Therapy (Business Wire)
Feb-10-26 04:01PM	CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (Business Wire)
Feb-03-26 07:05AM	CareDx to Present AlloHeme Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings (Business Wire)
Jan-27-26 04:05PM	CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Jan-13-26 10:45AM	NTRA & NVDA Partner to Improve AI Models for Precision Medicine (Zacks)
08:30AM	Implied Volatility Surging for CareDx Stock Options (Zacks)
Jan-12-26 08:57AM	RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models (Zacks) +20.08%
07:05AM	CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Jan-07-26 07:05AM	CareDx and 10x Genomics to Launch ImmuneScape Program - A Multiomics Research Platform to Decode Transplant Rejection and Drug Response (Business Wire)
Jan-06-26 10:48AM	Cigna Shares on the Couch: Time to Stay Strong or Walk Away Now? (Zacks) -5.05%
Dec-26-25 04:05PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-23-25 09:15AM	Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run? (Zacks)
Dec-18-25 05:00PM	CareDx Provides Notice of Proposed Derivative Settlement (Business Wire)
Nov-27-25 09:55AM	Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade (Zacks)
Nov-24-25 04:05PM	SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation (Business Wire)
Nov-07-25 04:05PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.91%
Nov-06-25 08:00AM	CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 (Business Wire) -9.20%
Nov-05-25 12:03AM	CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance (GuruFocus.com) +13.84%
Nov-04-25 07:00PM	CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:15PM	CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
05:12PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Announces Third Quarter 2025 Financial Results (Business Wire)
Nov-03-25 07:52AM	CareDx Inc (CDNA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-27-25 07:05AM	CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer (Business Wire)
Oct-23-25 04:05PM	CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure (Business Wire)
Oct-22-25 04:01PM	CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors (Business Wire)
Oct-21-25 08:00AM	CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025 (Business Wire)
Oct-06-25 07:05AM	CareDx Announces New IVD Products and IVDR Certification for AlloSeq Tx and QTYPE at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting (Business Wire)
Sep-02-25 04:01PM	CareDx Issues Comment Letter on Draft LCD Policy (Business Wire) -8.09%
Aug-26-25 01:08PM	CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential (Benzinga)
Aug-22-25 08:30AM	Do Options Traders Know Something About CareDx Stock We Don't? (Zacks)
Aug-21-25 04:01PM	CareDx to Participate in Wells Fargo Healthcare Conference (Business Wire)
Aug-12-25 08:00AM	Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors (Business Wire) +5.86%
Aug-06-25 06:30PM	Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings (Zacks) -7.86%
05:45PM	CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates (Zacks)
04:57PM	CareDx Announces Appointment of Nathan Smith as Chief Financial Officer (Business Wire)
04:43PM	CareDx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	CareDx Announces Second Quarter 2025 Financial Results (Business Wire)
12:56PM	CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation (Business Wire)
Aug-05-25 10:07AM	What To Expect From CareDx Inc (CDNA) Q2 2025 Earnings (GuruFocus.com)
Jul-31-25 04:01PM	CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress (Business Wire)
Jul-23-25 07:05AM	CareDx to Report Second Quarter 2025 Financial Results (Business Wire)
Jul-22-25 07:06AM	CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains? (Zacks)
Jul-18-25 08:00AM	CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection (Business Wire)
Jun-03-25 04:30PM	CareDx Announces Repurchase of 5% of Outstanding Shares (Business Wire) +10.67%
May-13-25 04:01PM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
May-01-25 03:17AM	CareDx Inc (CDNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments (GuruFocus.com) -10.72%
Apr-30-25 08:39PM	CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript (Seeking Alpha) -6.89%
05:50PM	CareDx (CDNA) Tops Q1 Earnings Estimates (Zacks)
04:50PM	CareDx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports First Quarter 2025 Results (Business Wire)
Apr-29-25 07:05AM	CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-24-25 07:05AM	CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-21-25 04:01PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-08-25 07:05AM	CareDx to Report First Quarter 2025 Financial Results (Business Wire)
Apr-04-25 12:40PM	Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock? (Zacks)
Mar-11-25 07:05AM	CareDx Launches Two Expanded Indications for AlloSure Testing Services (Business Wire)
Feb-27-25 02:20AM	CareDx Inc (CDNA) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

PresidentMr. John Walter Hanna Jr.

CPAMr. Keith S. Kennedy C.F.A.

General Counsel & SecretaryMr. Jeffrey A. Novack

Chief Commercial OfficerMs. Jessica Meng

Chief Technology OfficerMr. Kashif Rathore

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PETER MAAG	Director	Aug 17 '26	Proposed Sale	46.38	9,122	423,091		Aug 17 04:06 PM
PETER MAAG	Director	Aug 14 '26	Proposed Sale	45.30	7,000	317,113		Aug 14 06:09 PM
PETER MAAG	Director	Aug 13 '26	Proposed Sale	47.07	7,000	329,505		Aug 13 04:19 PM
PETER MAAG	Director	Aug 12 '26	Proposed Sale	46.89	7,000	328,238		Aug 12 04:08 PM
PETER MAAG	Director	Aug 11 '26	Proposed Sale	47.69	7,000	333,851		Aug 11 06:12 PM
PETER MAAG	Director	Aug 10 '26	Proposed Sale	47.66	6,902	328,949		Aug 10 06:23 PM
ARTHUR TORRES	Director	Aug 10 '26	Proposed Sale	47.73	4,200	200,475		Aug 10 04:17 PM
PETER MAAG	Director	Aug 07 '26	Proposed Sale	45.83	27,332	1,252,492		Aug 07 04:52 PM
Bickerstaff George	Director	Aug 05 '26	Sale	46.28	20,000	925,700	134,061	Aug 06 04:10 PM
COURNOYER CHRISTINE	Director	Aug 04 '26	Sale	46.94	16,000	750,973	42,943	Aug 06 04:10 PM
Novack Jeffrey Adam	Secretary and General Counsel	Aug 05 '26	Sale	46.26	2,688	124,349	106,075	Aug 06 04:05 PM
Goldberg Michael	Director	Aug 04 '26	Sale	47.06	44,700	2,103,497	61,738	Aug 06 04:05 PM
PETER MAAG	Director	Aug 05 '26	Proposed Sale	46.40	46,963	2,178,945		Aug 05 05:23 PM
JEFFREY NOVACK	Officer	Aug 05 '26	Proposed Sale	47.09	2,688	126,578		Aug 05 04:22 PM
GEORGE W BICKERSTAFF	Director	Aug 05 '26	Proposed Sale	46.28	20,000	925,700		Aug 05 04:15 PM
Christine M. Cournoyer	Director	Aug 04 '26	Proposed Sale	47.09	16,000	753,440		Aug 04 06:09 PM
CHRISTINE COURNOYER	Director	Aug 04 '26	Proposed Sale	47.53	31,943	1,518,142		Aug 04 04:38 PM
MICHAEL D. GOLDBERG FAM TRUST	Director	Aug 04 '26	Proposed Sale	47.06	44,700	2,103,497		Aug 04 04:28 PM
PETER MAAG	Director	Aug 04 '26	Proposed Sale	47.28	75,653	3,576,851		Aug 04 04:02 PM
Hanna John Walter JR	President and CEO	Jul 16 '26	Option Exercise	8.20	118,000	967,600	771,448	Jul 17 04:23 PM
Hanna John Walter JR	President and CEO	Jul 16 '26	Sale	37.79	118,000	4,458,637	653,448	Jul 17 04:23 PM
Valantine Hannah	Director	Jul 16 '26	Option Exercise	14.76	28,779	424,895	65,465	Jul 17 04:22 PM
Valantine Hannah	Director	Jul 16 '26	Sale	36.15	28,779	1,040,243	36,686	Jul 17 04:22 PM
JOHN WALTER HANNA	Director	Jul 16 '26	Proposed Sale	29.75	118,000	3,510,500		Jul 16 04:35 PM
HANNAH VALANTINE	Director	Jul 16 '26	Proposed Sale	29.75	28,779	856,175		Jul 16 04:33 PM
Hanna John Walter JR	President and CEO	Jun 29 '26	Option Exercise	8.20	39,900	327,180	701,859	Jun 30 05:29 PM
Hanna John Walter JR	President and CEO	Jun 15 '26	Option Exercise	8.20	15,676	128,543	661,959	Jun 30 05:29 PM
Hanna John Walter JR	President and CEO	Jun 11 '26	Option Exercise	8.20	13,618	111,668	646,283	Jun 30 05:29 PM
Hanna John Walter JR	President and CEO	Jun 04 '26	Option Exercise	8.20	706	5,789	632,665	Jun 30 05:29 PM
Hanna John Walter JR	President and CEO	Jun 26 '26	Option Exercise	8.20	100	820	662,059	Jun 30 05:29 PM
Hanna John Walter JR	President and CEO	Jun 29 '26	Sale	29.24	39,900	1,166,836	661,959	Jun 30 05:29 PM
Hanna John Walter JR	President and CEO	Jun 26 '26	Sale	29.00	100	2,900	661,959	Jun 30 05:29 PM
JOHN HANNA	Director	Jun 29 '26	Proposed Sale	28.82	39,500	1,138,390		Jun 29 04:42 PM
Hanna John Walter JR	President and CEO	Jun 15 '26	Sale	24.03	17,683	424,877	631,959	Jun 17 04:05 PM
Valantine Hannah	Director	Jun 15 '26	Sale	23.11	12,103	279,728	36,686	Jun 16 05:51 PM
Hanna John Walter JR	President and CEO	Jun 11 '26	Sale	24.02	21,998	528,443	649,642	Jun 15 05:06 PM
HANNAH VALANTINE	Director	Jun 15 '26	Proposed Sale	22.97	12,103	278,006		Jun 15 04:59 PM
JOHN HANNA	Director	Jun 11 '26	Proposed Sale	23.46	40,181	942,646		Jun 11 04:24 PM
Hanna John Walter JR	President and CEO	Jun 04 '26	Sale	24.00	4,835	116,045	671,640	Jun 08 04:05 PM
JOHN WALTER HANNA	Director	Jun 04 '26	Proposed Sale	22.31	4,835	107,869		Jun 04 04:32 PM
TORRES ARTHUR A	Director	May 15 '26	Sale	19.89	6,484	128,978	38,665	May 18 04:05 PM
TORRES ARTHUR A	Director	May 14 '26	Sale	20.97	4,086	85,698	45,149	May 18 04:05 PM
ARTHUR TORRES	Director	May 15 '26	Proposed Sale	19.89	6,484	128,978		May 15 04:46 PM
ARTHUR TORRES	Director	May 14 '26	Proposed Sale	20.97	4,086	85,698		May 14 06:44 PM
Novack Jeffrey Adam	Secretary and General Counsel	May 05 '26	Sale	20.68	2,688	55,581	113,924	May 06 04:05 PM
JEFFREY NOVACK	Officer	May 05 '26	Proposed Sale	20.96	2,688	56,340		May 05 04:32 PM
Hanna John Walter JR	President and CEO	Apr 16 '26	Sale	21.12	10,282	217,156	676,475	Apr 20 04:53 PM
JOHN HANNA	Director	Apr 16 '26	Proposed Sale	17.57	10,282	180,655		Apr 16 04:12 PM
Goldberg Michael	Director	Mar 31 '26	Option Exercise	3.35	26,500	88,648	183,961	Apr 01 04:10 PM
Novack Jeffrey Adam	Secretary and General Counsel	Feb 03 '26	Sale	20.56	4,441	91,286	125,364	Feb 04 04:22 PM
JEFFREY NOVACK	Officer	Feb 03 '26	Proposed Sale	20.42	4,441	90,685		Feb 03 04:33 PM
Hanna John Walter JR	President and CEO	Jan 22 '26	Sale	21.16	19,280	408,023	597,405	Jan 23 05:58 PM
Hanna John Walter JR	President and CEO	Jan 21 '26	Sale	21.00	200	4,200	616,685	Jan 23 05:58 PM
Hanna John Walter JR	President and CEO	Jan 15 '26	Sale	21.05	10,156	213,804	616,885	Jan 20 05:30 PM
JOHN HANNA	Director	Jan 15 '26	Proposed Sale	20.32	29,636	602,204		Jan 15 04:40 PM
Novack Jeffrey Adam	Secretary and General Counsel	Dec 04 '25	Sale	19.17	7,293	139,804	97,925	Dec 05 04:07 PM
JEFFREY NOVACK	Officer	Dec 04 '25	Proposed Sale	18.85	7,293	137,473		Dec 04 04:39 PM
Novack Jeffrey Adam	Secretary and General Counsel	Nov 07 '25	Sale	15.52	2,688	41,723	105,218	Nov 10 04:14 PM
Jeffrey Adam Novack	Officer	Nov 07 '25	Proposed Sale	15.01	2,688	40,347		Nov 07 04:37 PM
ABHISHEK JAIN	Officer	Nov 05 '25	Proposed Sale	15.77	53,388	842,050		Nov 05 04:21 PM
ABHISHEK JAIN	Officer	Oct 31 '25	Proposed Sale	14.90	9,964	148,464		Oct 31 04:48 PM
Bickerstaff George	Director	Sep 11 '25	Option Exercise	7.96	29,136	231,923	144,266	Sep 12 05:09 PM

SPOK

Spok Holdings Inc

CDNA

Caredx Inc

Upgrade your Finviz experience